Characterization of CD44v3 containing isoforms in head and neck cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Biology & Therapy

• Publication date

  2006-08-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cbt.5.9.3065PMID 16855392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer

  2005cited by this paper
• Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck.

  2005cited by this paper
• Structural heterogeneity of human Pgp-1 and its relationship with p85

  2004cited by this paper
• Molecular Diagnosis of Surgical Margins and Local Recurrence in Head and Neck Cancer Patients

  2004cited by this paper
• Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3.

  2003cited by this paper
• CD44: From adhesion molecules to signalling regulators

  2003cited by this paper
• Antagonistic Signaling Pathways Regulate Alternative Splicing of CD44 in T Cells

  2002cited by this paper
• Head and neck cancer.

  2001cited by this paper
• Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means?

  2000cited by this paper
• A novel CD44v3 isoform is involved in head and neck squamous cell carcinoma progression

  1999cited by this paper
• A Novel CD44 v3 Isoform is Involved in Head and Neck Squamous Cell Carcinoma Progression

  1999cited by this paper
• Estimates of the worldwide incidence of 25 major cancers in 1990

  1999cited by this paper
• CD44: structure, function, and association with the malignant process.

  1997cited by this paper
• Altered expression of CD44 isoforms in squamous‐cell carcinomas and cell lines derived from them

  1996cited by this paper
• The Cell Adhesion Molecule, GP116, Is a New CD44 Variant (ex14/v10) Involved in Hyaluronic Acid Binding and Endothelial Cell Proliferation*

  1996cited by this paper
• New CD44 splice variants associated with human breast cancers

  1995cited by this paper
• CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

  1995cited by this paper
• Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis

  1995cited by this paper
• Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer

  1995cited by this paper
• Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon

  1995cited by this paper
• CD44 expression patterns in breast and colon tumors: A pcr‐based study of splice variants

  1995cited by this paper
• CD44 variant exon epitopes in primary breast cancer and length of survival.

  1995cited by this paper
• Upper aerodigestive tract cancers

  1995cited by this paper
• Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.

  1994cited by this paper
• Significance of CD44 gene products for cancer diagnosis and disease evaluation.

  1992cited by this paper
• Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

  1992cited by this paper
• Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons

  1991cited by this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cited by this paper
• Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis.

  1991cited by this paper
• Head and neck cancer.

  1991cited by this paper
• Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin

  1988cited by this paper
• Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues

  1982cited by this paper

• CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker

  2025cites this paper
• Meta-Analysis of Prognostic Significance of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma

  2024cites this paper
• Alternative Splicing of Pre-mRNA Matters in Oral Diseases.

  2024cites this paper
• Expression of CD44 in Head and Neck Squamous Cell Carcinoma—An In-Silico Study

  2023cites this paper
• Association of high expression of CD44 in clinicopathological factors of endometrial cancer.

  2023cites this paper
• Feline SCCs of the Head and Neck Display Partial Epithelial-Mesenchymal Transition and Harbor Stem Cell-like Cancer Cells

  2023cites this paper
• Evaluation of Immunoregulatory Biomarkers on Plasma Small Extracellular Vesicles for Disease Progression and Early Therapeutic Response in Head and Neck Cancer

  2022cites this paper
• 1,2,3,4,6-Penta-O-galloyl-β-D-glucose Inhibits CD44v3, a cancer stem cell marker, by regulating its transcription factor, in human pancreatic cancer cell line

  2022cites this paper
• Immunohistochemical expression of p53, Ki67, α-SMA, CD44 and CD31 in different histological subtypes of basal cell carcinoma

  2022cites this paper
• Modulation of cancer stemness property in head and neck cancer cells via circulatory fluid shear stress

  2022cites this paper
• The state of CD44 activation in cancer progression and therapeutic targeting

  2021cites this paper
• The role of CD44 in cancer chemoresistance: a concise review.

  2021cites this paper
• Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics

  2020cites this paper
• Don’t sugarcoat it: How glycocalyx composition influences cancer progression

  2019cites this paper
• CNTs mediated CD44 targeting; a paradigm shift in drug delivery for breast cancer

  2019cites this paper
• Head and neck cancer management and cancer stem cells implication

  2019cites this paper
• Role of CD44 in breast cancer

  2019cites this paper
• Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence

  2018cites this paper
• Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma

  2018cites this paper
• The biology and role of CD44 in cancer progression: therapeutic implications

  2018cites this paper
• Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer

  2018cites this paper
• Receptor‐Targeted Drug Delivery and the (Many) Problems We Know of: The Case of CD44 and Hyaluronic Acid

  2018cites this paper
• Hyaluronan-Mediated CD44 Signaling Activates Cancer Stem Cells in Head and Neck Cancer

  2018cites this paper
• Increased Expression of CD44v9, A Cancer Stem Cell Marker, in Head And Neck Squamous Cell Carcinoma Cells after Irradiation

  2017cites this paper
• The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer

  2016influential citation
• Development of a sandwich enzyme-linked immunosorbent assay for the detection of CD44v3 using exon v3- and v6-specific monoclonal antibody pairs.

  2016influential citation
• The potential of CD44 as a diagnostic and prognostic tool in oral cancer.

  2015cites this paper
• Clinical Implications of Cancer Stem Cell Properties in Oral Squamous Cell Carcinoma.

  2014cites this paper
• The Evolving Concepts of Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma

  2014cites this paper
• Immunohistochemical expression of E-cadherin and CD44 adhesion molecules in oral squamous cell carcinoma

  2013cites this paper
• Characterization of CD44 variant expression in head and neck squamous cell carcinomas

  2013cites this paper
• MicroRNA-143 Inhibits Migration and Invasion of Human Non-Small-Cell Lung Cancer and Its Relative Mechanism

  2013cites this paper
• Siekalu dziedzeru un oronazofaringeālo audzēju klīniskā un morfoloģiskā izpēte, herpes grupas vīrusu lomas analīze malignā procesā. Promocijas darbs

  2013cites this paper
• CD44 Expression in Oro-Pharyngeal Carcinoma Tissues and Cell Lines

  2012cites this paper
• Oropharyngeal malignant epithelial cell, lymphocyte and macrophage CD44 surface receptors for hyaluronate are expressed in sustained EBV infection: immunohistochemical data and EBV DNA tissue indices.

  2012cites this paper
• Regulation of CD44 expression by tumor necrosis factor-α and its potential role in breast cancer cell migration.

  2012cites this paper
• Establishment of a Cell Line (CNUH-HNSCC-1) Derived from an Advanced Laryngeal Squamous Cell Carcinoma

  2011cites this paper
• Salivary markers and risk factor data: A multivariate modeling approach for head and neck squamous cell carcinoma detection

  2011cites this paper
• Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.

  2011cites this paper
• UNIVERSITÀ DEGLI STUDI MILANO-BICOCCA FACOLTÀ DI MEDICINA E CHIRURGIA Dottorato di Ricerca in Parodontologia Sperimentale CORRELAZIONI ESISTENTI TRA PARODONTOLOGIA E MEDICINA ORALE. LESIONI DELLE MUCOSE ORALI VS MALATTIA PARODONTALE: ASPETTI DIAGNOSTICI E TERAPEUTICI.

  2010cites this paper
• Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer.

  2010cites this paper
• Oral squamous cell carcinoma overview.

  2009cites this paper
• Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications.

  2009cites this paper
• Functional Aspects of the Hyaluronan and Chondroitin Sulfate Receptors

  2009cites this paper
• CD44 variant isoforms in head and neck squamous cell carcinoma progression

  2009cites this paper
• Oral cancer: current and future diagnostic techniques.

  2008cites this paper
• Cancer stem cells: markers or biomarkers?

  2008cites this paper
• World Journal of Stem Cells

  year unknowncites this paper